Latest News

Study indicates overtreatment of men with prostate cancer and limited life expectancy
Study indicates overtreatment of men with prostate cancer and limited life expectancy

November 20th 2024

“Prostate cancer patients with life expectancies of less than 5 or 10 years were being subjected to treatments that can take up to a decade to significantly improve their chances of surviving cancer, despite guidelines recommending against treatment," says Timothy J. Daskivich, MD.

Phase 1/2 trial launches of CAR T cell therapy for ccRCC
Phase 1/2 trial launches of CAR T cell therapy for ccRCC

November 20th 2024

QUILT 3.032 trial: Anktiva achieves high response rate in BCG-unresponsive NMIBC
QUILT 3.032 trial: Anktiva achieves high response rate in BCG-unresponsive NMIBC

November 19th 2024

Head-to-head trial to compare 64Cu-SAR-bisPSMA and 68Ga-PSMA-11 PET/CT
Head-to-head trial to compare 64Cu-SAR-bisPSMA and 68Ga-PSMA-11 PET/CT

November 19th 2024

Survey sheds light on international genetic testing patterns in prostate cancer
Survey sheds light on international genetic testing patterns in prostate cancer

November 18th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.